Pathobiology of Prediabetes in A Bi-Racial Cohort
双种族队列中糖尿病前期的病理学
基本信息
- 批准号:7588751
- 负责人:
- 金额:$ 52.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-01 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:African AmericanBeta CellBody CompositionBody fatCardiovascular systemCaucasiansCaucasoid RaceCell physiologyCommunitiesDataDevelopmentDiabetes MellitusDiseaseEnergy MetabolismEthnic groupFunctional disorderFutureGlucoseImpaired fasting glycaemiaImpairmentIncidenceIndividualInsulinInterventionLeptinLipoproteinsMediator of activation proteinMetabolicMetabolic MarkerMetabolic syndromeMorbidity - disease rateNational Institute of Diabetes and Digestive and Kidney DiseasesNatural HistoryNon-Insulin-Dependent Diabetes MellitusParentsParticipantPathogenesisPersonsPhysical activityPopulationPrediabetes syndromePrevalencePreventivePreventive InterventionPrimary PreventionProspective StudiesPublic HealthRaceReportingRiskRisk MarkerSocioeconomic StatusStagingTestingcardiovascular risk factorcohortdiabetes prevention programethnic differencefollow-upgenetic analysisglucose tolerancehealth disparityhigh riskimpaired glucose toleranceimprovedinsulin secretioninsulin sensitivitymortalitynoveloffspringprogramsresponsesocioeconomics
项目摘要
This proposal is in response to ProgramAnnouncement Number PA-04-074, "Health Disparities inNIDDK
Disease." In contrast to the widely reported ethnic differences in prevalence, the incidence of type 2
diabetes was surprisingly similar (~11%) among individuals from the different U.S. ethnic groups inthe
Diabetes Prevention Program(DPP). Because DPP participants had impaired glucose tolerance (IGT) at
baseline, the finding of similar incident diabetes rates led us to hypothesizethat ethnic disparities are
initiated much earlier during the pathogenesis of type 2 diabetes than is commonly realized. We,therefore,
propose to study ethnic disparities proximal to the stage of prediabetes (IGT and impaired fastingglucose
{IFG}). We will compare the rates of progression from normal glucosetolerance (NGT) to prediabetes in 200
African-American and 200 Caucasian offspring of parents with type 2 diabetes. Compared with NGT
subjects, persons with prediabetes (e.g., IGT) have a two-fold increased risk of fatal cardiovasculardisease
(CVD). Yet, few prospective studies exist on the natural history, predictors, mechanisms, and mediatorsof
progression from NGT to prediabetes in any population, and none in African-Americans. We arguethat
focusing on this early period is of public health significance, because the IGT stage may already betoo late
for complete reversal of metabolic and cardiovascular sequelae. In our proposed study, initially NGTsubjects
at high risk for type 2 diabetes will undergo repeated metabolic assessments, including glucosetolerance,
insulin sensitivity, beta cell function, adipocytokines, CVD risk markers,and socioeconomic and other
pertinent endpoints for 5 years. DNAspecimens will be stored for future genetic analysis. The primary
endpoint is progression from NGTto prediabetes. Secondaryendpoints include changes in caloricintake,
physical activity, body composition, insulin sensitivity, insulin secretion, lipoproteins, adipocytokines,
proinflammatory markers and other known or putative predictors of glycemic dysregulation. Bycomparing
these endpoints between Progressorsand Nonprogressors and African-Americans vs. Caucasianswe hope
to provide novel data on the natural history of prediabetes, and determine whether ethnic disparities are
programmed during the transition from NGT to prediabetes.
Increased understanding of the variousfactors that trigger the changefrom normal glucose to prediabetes
would enable the discovery of early preventive interventions beforefull blown diabetes and its related
complications become established. Furthermore, understanding howthese factors differ acrossethnic
groups will improve our ability to better target preventive measuresin different communities.
本提案是对PA-04-074号计划公告“NIDDK中的健康差异”的回应
疾病“与广泛报道的患病率的种族差异相反,2型糖尿病的发病率
糖尿病在美国不同种族人群中惊人地相似(~11%)。
糖尿病预防计划(DPP)。由于DPP参与者在以下时间点葡萄糖耐量受损(IGT),
基线,发现类似的糖尿病发病率使我们假设种族差异是
在2型糖尿病的发病过程中比通常认识到的更早开始。因此,我们
我建议研究接近糖尿病前期阶段(IGT和空腹血糖受损)的种族差异
{IFG})。我们将比较200例正常葡萄糖耐量(NGT)患者进展为糖尿病前期的速度,
非裔美国人和200名白人后代的父母患有2型糖尿病。与NGT相比
受试者,患有前驱糖尿病的人(例如,IGT)患致命性心血管疾病的风险增加两倍
(CVD)。然而,很少有前瞻性的研究存在的自然历史,预测,机制,和介导的
在任何人群中从NGT进展为糖尿病前期,在非洲裔美国人中没有。我们感谢
关注这一早期阶段具有公共卫生意义,因为IGT阶段可能已经太晚
完全逆转代谢和心血管后遗症。在我们提出的研究中,最初NGT受试者
2型糖尿病高危人群将接受反复的代谢评估,包括葡萄糖耐量,
胰岛素敏感性、β细胞功能、脂肪细胞因子、CVD风险标志物以及社会经济和其他因素
5年的相关终点。DNA样本将被储存用于未来的遗传分析。主
终点是从NGT进展为前驱糖尿病。次要终点包括热量摄入的变化,
身体活动、身体组成、胰岛素敏感性、胰岛素分泌、脂蛋白、脂肪细胞因子,
促炎标志物和其他已知或推定的血糖失调的预测因子。通过对比
我们希望这些进展者和非进展者以及非洲裔美国人和白人之间的终点
提供关于糖尿病前期自然史的新数据,并确定种族差异是否
在从NGT到前驱糖尿病的过渡期间编程。
增加对触发从正常血糖到糖尿病前期变化的各种因素的理解
能够在糖尿病及其相关疾病全面爆发之前发现早期预防干预措施,
并发症已经形成。此外,了解这些因素在不同种族之间的差异,
团体将提高我们在不同社区更好地采取预防措施的能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SAMUEL DAGOGO-JACK, M.D., D.Sc.其他文献
SAMUEL DAGOGO-JACK, M.D., D.Sc.的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SAMUEL DAGOGO-JACK, M.D., D.Sc.', 18)}}的其他基金
Ceramides and Sphingolipids as Predictors of Incident Dysglycemia
神经酰胺和鞘脂作为血糖异常事件的预测因子
- 批准号:
10361527 - 财政年份:2021
- 资助金额:
$ 52.18万 - 项目类别:
Ceramides and Sphingolipids as Predictors of Incident Dysglycemia
神经酰胺和鞘脂作为血糖异常事件的预测因子
- 批准号:
10578762 - 财政年份:2021
- 资助金额:
$ 52.18万 - 项目类别:
Ceramides and Sphingolipids as Predictors of Incident Dysglycemia
神经酰胺和鞘脂作为血糖异常事件的预测因子
- 批准号:
10182413 - 财政年份:2021
- 资助金额:
$ 52.18万 - 项目类别:
Pathobiology of Prediabetes in A Bi-Racial Cohort
双种族队列中糖尿病前期的病理学
- 批准号:
7213361 - 财政年份:2006
- 资助金额:
$ 52.18万 - 项目类别:
Pathobiology and Reversibility of Prediabetes in a Biracial Cohort
混血儿群体中糖尿病前期的病理学和可逆性
- 批准号:
8734383 - 财政年份:2006
- 资助金额:
$ 52.18万 - 项目类别:
Pathobiology and Reversibility of Prediabetes in a Biracial Cohort
混血儿群体中糖尿病前期的病理学和可逆性
- 批准号:
8580480 - 财政年份:2006
- 资助金额:
$ 52.18万 - 项目类别:
Pathobiology of Prediabetes in A Bi-Racial Cohort
双种族队列中糖尿病前期的病理学
- 批准号:
7408584 - 财政年份:2006
- 资助金额:
$ 52.18万 - 项目类别:
Pathobiology of Prediabetes in A Bi-Racial Cohort
双种族队列中糖尿病前期的病理学
- 批准号:
7081734 - 财政年份:2006
- 资助金额:
$ 52.18万 - 项目类别:
相似海外基金
Understanding how exocrine-derived signals promote beta cell growth
了解外分泌信号如何促进 β 细胞生长
- 批准号:
10750765 - 财政年份:2024
- 资助金额:
$ 52.18万 - 项目类别:
Sustaining functional maturity of pancreatic beta cell through nutritional control
通过营养控制维持胰腺β细胞的功能成熟
- 批准号:
23H03304 - 财政年份:2023
- 资助金额:
$ 52.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Beta cell rest を目指した新たな2型糖尿病治療法の確立
建立针对 β 细胞休息的新型 2 型糖尿病治疗方法
- 批准号:
23K07959 - 财政年份:2023
- 资助金额:
$ 52.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Graft localized drug delivery to augment beta cell replacement therapies for diabetes
移植局部药物递送以增强糖尿病的β细胞替代疗法
- 批准号:
480374 - 财政年份:2023
- 资助金额:
$ 52.18万 - 项目类别:
Operating Grants
PITPNA in pancreatic beta-cell dysfunction and diabetes pathogenesis
PITPNA 在胰腺 β 细胞功能障碍和糖尿病发病机制中的作用
- 批准号:
10636228 - 财政年份:2023
- 资助金额:
$ 52.18万 - 项目类别:
The Influence of Developmental Exposure to Maternal Overnutrition and Metformin on Offspring Mitochondrial Health and Beta Cell Function
发育期暴露于母亲营养过剩和二甲双胍对后代线粒体健康和 β 细胞功能的影响
- 批准号:
10601500 - 财政年份:2023
- 资助金额:
$ 52.18万 - 项目类别:
Nutrient-sensor O-GlcNAc Transferase Regulation of Autophagy in Homeostatis of Pancreatic Beta-cell Mass and Function
营养传感器 O-GlcNAc 转移酶对胰腺 β 细胞质量和功能稳态中自噬的调节
- 批准号:
10907874 - 财政年份:2023
- 资助金额:
$ 52.18万 - 项目类别:
New strategies in cell replacement therapies for diabetes: role of USP7 in iPSC and adult organoids beta cell differentiation
糖尿病细胞替代疗法的新策略:USP7 在 iPSC 和成体类器官 β 细胞分化中的作用
- 批准号:
MR/X01813X/1 - 财政年份:2023
- 资助金额:
$ 52.18万 - 项目类别:
Research Grant
Effect of Dietary Carbohydrate on Diabetes Control and Beta Cell Function in Children with Newly Diagnosed Diabetes.”
膳食碳水化合物对新诊断糖尿病儿童的糖尿病控制和 β 细胞功能的影响。
- 批准号:
10637032 - 财政年份:2023
- 资助金额:
$ 52.18万 - 项目类别:
Development of platforms for beta cell-specific delivery and ligand discovery
开发β细胞特异性递送和配体发现平台
- 批准号:
10738505 - 财政年份:2023
- 资助金额:
$ 52.18万 - 项目类别: